All Pharma News
CG Oncology Begins Dosing in Japan in Phase 3 Monotherapy Study of CG0070

CG Oncology Begins Dosing in Japan in Phase 3 Monotherapy Study of CG0070
BUSINESSWIRE
20 Dec 2021
Share Share
VFMCRP announces approval for TAVNEOS for ANCA-associated vasculitis in Japan

VFMCRP announces approval for TAVNEOS for ANCA-associated vasculitis in Japan
BUSINESSWIRE
27 Sep 2021
Share Share
Licensing Agreement for GnRH Antagonist Linzagolix with Bio Genuine in China

Licensing Agreement for GnRH Antagonist Linzagolix with Bio Genuine in China
KISSEI
02 Sep 2021
Share Share
Launch of UPASITA for the Treatment of Secondary Hyperparathyroidism

Launch of UPASITA for the Treatment of Secondary Hyperparathyroidism
PRESS RELEASE
19 Aug 2021
Share Share
Licensing Agreement with Affamed for KDT-3594, a Novel Investigational Drug

Licensing Agreement with Affamed for KDT-3594, a Novel Investigational Drug
PRESSRELEASE
09 Oct 2020
Share Share
Rigel`s fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharma

Rigel`s fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharma
PR NEWSWIRE
23 Sep 2019
Share Share
Sanofi, Eisai join Lilly`s SCOTUS bid to save Cialis from patent claims

Sanofi, Eisai join Lilly`s SCOTUS bid to save Cialis from patent claims
Kyle Blankenship FIERCE PHARMA
09 Jul 2019
Share Share
Imbruvica (ibrutinib): Pharmacyclics, Janssen Biotech vs. Hetero Labs

Imbruvica (ibrutinib): Pharmacyclics, Janssen Biotech vs. Hetero Labs
PATENT LITIGATION
24 Nov 2018
Share Share
Velcade (Bortezomib): Millennium Pharmaceuticals vs Hetero Labs Limited

Velcade (Bortezomib): Millennium Pharmaceuticals vs Hetero Labs Limited
PATENT LITIGATION
24 Nov 2018
Share Share
Kyorin Receives Marketing Approval in Japan for

Kyorin Receives Marketing Approval in Japan for "Beova® Tablets 50mg" for OAB
PRESS RELEASE
21 Sep 2018
Share Share